November 9, 2017 / 1:14 PM / a month ago

BRIEF-Eiger Biopharmaceuticals reports Q3 loss per share $1.10

Nov 9 (Reuters) - Eiger Biopharmaceuticals Inc

* Eiger Biopharmaceuticals reports third quarter 2017 financial results

* Q3 loss per share $1.10

* Q3 earnings per share view $-1.28 -- Thomson Reuters I/B/E/S

* Eiger Biopharmaceuticals - ‍As of Sept 30, 2017, Eiger had cash, cash equivalents and short-term marketable securities of $32.3 million

* Eiger Biopharmaceuticals Inc - ‍Company estimates its cash runway now extends into mid-2019​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below